from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv3369/-

LFCtreatmentdescriptionclass of inhibitor

0.772

Amikacinug/mL Amikacintranslation

0.971

Cap5-10ug/mL Capreomycintranslation

-0.342

Rox10-50 ug/mL Roxithromycintranslation

-0.499

SM2-5 ug/mL Streptomycintranslation

2.098

Tet5-10 ug/mL Tetracyclinetranslation

0.680

Rif0.2-5ug/mL Rifampicintranscription

0.098

Rifp0.1-0.5ug/mL Rifapentinetranscription

-0.009

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

1.248

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

-0.192

CPZ10-50 ug/mL Chlorpromazinerespiration

-0.400

Clofazimine10-13 ug/mL Clofaziminerespiration

0.191

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

-0.098

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

0.962

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

0.493

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

1.030

Econazole10-24 ug/mL Econazole (azole drug)respiration

-0.173

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

0.030

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

-0.001

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

0.272

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

-1.519

KCN5-20 ug/mL Potassium cyaniderespiration

0.278

NaN30.2-2 mM Sodium aziderespiration

-0.488

Nigericin50 uM Nigericinrespiration

0.549

TRC10-150 ug/mL Triclosanrespiration

0.469

TRZ10-25 ug/mL Thioridazinerespiration

-0.827

Valinomycin0.5-10 uM Valinomycinrespiration

-1.665

ZnSO42 mM ZnSO4respiration

-0.225

menadione6-10 ug/mL Menadionerespiration

-0.419

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

-0.978

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

-0.851

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

-0.415

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

-0.325

NRP_1Non-replicating persistence stage 1dosRassociated

-0.842

Amp0.2mg/mL AmpicillincellWall

0.359

Cephalexin20-100 ug/mL CephalexincellWall

-0.528

Cerulenin0.32-5 ug/mL CerulenincellWall

-1.511

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

-0.803

EMB10-20 ug/mL EthambutolcellWall

0.504

Eta12-40 ug/mL EthionamidecellWall

0.480

INH0.2-0.4 ug/mL IsoniazidcellWall

0.232

TLM0.1-0.2 mg/mL ThiolactomycincellWall

0.756

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

0.396

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

0.298

BZA0.12 mg/mL BenzamidearomaticAmides

0.245

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

0.198

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

0.337

H2O24 mM hydrogen peroxideDNAdamaging

1.949

Levo10 ug/mL LevofloxacinDNAdamaging

-0.259

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

0.798

Novobiocin10 ug/mL NovobiocinDNAdamaging

0.554

Oflox5-10 ug/mL OfloxacinDNAdamaging

-0.231

UVUV-irradiationDNAdamaging

0.664

ARP41-4 ug/mL Antitubercular compound ARP4?

0.090

Antimycin12.5-50 ug/mL Antimycin A?

0.103

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

0.710

PA_110-50 ug/mL Antitubercular compound PA-1?

-0.139

PA_2110-50 ug/mL Antitubercular compound PA-21?

-0.539

PA8240.2-2 ug/mL PA-824?

-0.601

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

-0.024

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

-0.081

Verapamil50 uM Verapamil?

0.510

mercaptoethanol2 mM 2-Mercaptoethanol?

0.163

methoxatin10-20 ug/mL Methoxatin?